Quick Answer
BIOVIE INC. reported Cash and Equivalents of $17.54 million for fiscal year 2025.
BIOVIE INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $17.54M | -26.4% |
| 2024 | $23.84M | +22.5% |
| 2023 | $19.46M | +4.4% |
| 2022 | $18.64M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $20.54M | -15.8% | -17.8% |
| September 30, 2025 | $24.98M | +24.7% | +42.4% |
| June 30, 2025 | $17.54M | -26.4% | -24.2% |
| March 31, 2025 | $23.15M | -23.7% | -5.1% |
| December 31, 2024 | $24.41M | +20.7% | +21.9% |
| September 30, 2024 | $20.02M | -5.6% | -16.0% |
| June 30, 2024 | $23.84M | +22.5% | -21.4% |
| March 31, 2024 | $30.35M | -3.0% | +50.1% |
- BIOVIE INC. showed a decrease of -26.4% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2022–2025 period, BIOVIE INC.’s cash and equivalents has declined by 5.9% (from $18.64 million to $17.54 million).
- The most recent figure is from BIOVIE INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: